Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
PFE | Pfizer Inc. | 0.06% | 36.72 | 0.9% | $1162.21m | |
JNJ | Johnson & Johnson | 1.42% | 162.58 | 0.7% | $1092.50m | |
LLY | Eli Lilly & Co. | 3.43% | 197.32 | 1.1% | $727.56m | |
ABBV | AbbVie, Inc. | 1.03% | 111.66 | 1.9% | $710.61m | |
MRK | Merck & Co., Inc. | -0.25% | 83.18 | 0.7% | $682.27m | |
BMY | Bristol-Myers Squibb Co. | -0.06% | 66.50 | 1.0% | $677.21m | |
AZN | AstraZeneca Plc | 2.23% | 52.49 | 1.2% | $644.28m | |
ARCT | Arcturus Therapeutics Holdings, Inc. | 12.81% | 67.34 | 0.0% | $231.55m | |
VTRS | Viatris, Inc. | 1.81% | 17.36 | 0.0% | $195.54m | |
RPRX | Royalty Pharma Plc | 1.40% | 52.68 | 0.2% | $176.33m | |
NVS | Novartis AG | 1.04% | 96.63 | 0.2% | $172.41m | |
GSK | GlaxoSmithKline Plc | 0.07% | 38.50 | 0.2% | $140.32m | |
SNY | Sanofi | 1.82% | 50.29 | 0.2% | $115.85m | |
RGEN | Repligen Corp. | 2.83% | 221.58 | 6.9% | $77.79m | |
NVO | Novo Nordisk A/S | 0.96% | 72.72 | 0.1% | $71.51m |
Company Profile
Kinnate Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA.